Sellas life sciences group, inc. (SLS)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Dec'10
ASSETS
Current assets:
Cash and cash equivalents

6,700

7,277

9,119

12,751

2,600

5,337

9,968

1,349

3,474

2,319

12,914

18,073

27,640

18,083

24,514

19,600

34,709

29,730

34,812

45,279

52,860

23,650

24,647

39,162

52,427

47,787

51,396

20,919

17,481

32,807

15,423

19,228

8,701

11,433

15,693

17,933

6,891

Restricted cash and cash equivalents

100

100

100

114

114

114

114

8,646

8,612

10,431

12,372

13,597

13,590

18,022

18,901

24,400

401

401

401

200

200

200

200

200

200

200

100

102

102

101

101

101

101

101

-

-

0

Stock subscription receivable

0

308

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other receivable

-

-

-

-

-

-

6,600

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,837

5,786

9,709

2,678

-

-

-

-

-

-

-

Accounts receivable, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,818

1,060

-

1,435

2,152

1,466

-

1,543

-

-

0

-

-

-

-

-

-

-

Inventories

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,426

637

655

450

433

358

-

425

352

-

0

-

-

-

-

-

-

-

Litigation settlement insurance recovery

-

-

-

-

-

-

474

-

-

-

-

-

-

-

0

0

1,700

21,700

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid Expense and Other Assets, Current

1,944

557

977

776

726

387

651

931

986

337

520

434

449

581

1,043

1,210

1,051

1,398

1,174

2,399

2,564

1,237

1,789

1,737

1,328

130

485

389

210

535

801

760

290

276

494

259

150

Current assets of discontinued operations

-

-

-

-

-

-

-

-

-

-

830

189

367

813

0

83

88

392

17,801

-

-

27,013

-

-

-

20,668

-

-

-

-

-

-

-

-

-

-

-

Total current assets

8,790

8,242

10,211

13,641

3,416

5,838

17,807

10,926

13,072

13,087

26,636

32,293

42,046

37,499

44,458

45,284

37,949

53,621

54,188

51,122

57,321

52,100

28,521

43,684

55,779

68,785

56,786

27,548

27,502

36,121

16,325

20,089

9,092

11,810

16,187

18,192

7,041

Operating lease right-of-use asset

123

217

306

390

471

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Equipment and furnishings, net

-

-

-

-

-

-

-

-

-

-

123

148

173

199

226

259

299

335

288

532

528

285

589

623

653

314

545

467

27

29

31

34

351

393

430

436

419

In-process research and development

5,700

5,700

8,500

8,500

8,500

8,500

17,600

17,600

17,600

17,600

9,300

12,864

12,864

12,864

12,864

12,864

12,864

12,864

12,864

12,864

12,864

12,864

12,864

12,864

12,864

12,864

12,864

12,864

12,864

12,864

12,864

12,864

12,864

12,864

12,864

12,864

0

GALE-401 rights

-

-

-

-

-

-

-

-

-

-

8,100

9,255

-

9,255

-

-

-

9,255

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Abstral rights, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

13,946

14,387

-

14,714

14,784

14,882

-

15,032

15,083

15,086

0

-

-

-

-

-

-

-

Zuplenz rights

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

8,101

8,101

-

7,663

-

-

-

-

-

-

-

-

-

-

-

-

-

-

GALE-401 rights

-

-

-

-

-

-

-

-

-

-

8,100

9,255

9,255

9,255

9,255

9,255

9,255

9,255

9,255

9,255

9,255

9,255

9,155

2,315

2,110

0

-

-

-

-

-

-

-

-

-

-

-

Goodwill

1,914

1,914

1,914

1,914

1,914

1,900

1,914

1,914

1,914

1,914

5,386

5,898

5,898

5,898

5,898

5,898

5,898

5,898

5,898

6,069

6,069

5,897

5,898

5,898

5,898

5,898

5,898

5,898

5,898

5,898

5,898

5,898

5,898

5,898

845

845

0

Deposits and other assets

499

536

553

589

626

663

1,149

1,533

899

925

50

96

96

96

145

218

100

171

176

78

82

87

88

108

104

115

129

142

74

74

74

74

3

3

3

16

16

Total assets

17,026

16,609

21,484

25,034

14,927

16,915

38,470

31,973

33,485

33,526

49,595

60,554

70,332

65,811

72,846

73,778

66,365

82,144

82,669

101,967

108,607

80,488

79,492

80,276

92,290

87,976

91,254

62,002

61,451

54,986

35,192

38,959

28,208

30,968

30,329

32,353

7,476

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Current contingent purchase price consideration

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

247

0

929

935

925

897

898

1,782

1,632

768

0

Current portion of long-term debt

-

-

-

-

-

-

76

7,779

8,526

8,377

12,170

13,025

12,597

16,397

23,722

23,157

3,740

4,739

4,166

4,079

3,994

3,910

4,163

4,076

3,102

2,149

1,215

301

-

0

-

-

-

-

-

-

-

Accounts payable

2,624

3,902

3,764

3,762

4,638

3,755

7,238

12,099

11,451

11,691

211

385

1,163

840

894

1,273

1,019

1,597

1,238

2,318

3,293

1,886

3,360

2,036

1,574

1,907

1,890

2,092

2,123

1,976

2,210

1,706

2,581

2,155

1,462

1,065

724

Accrued expenses and other current liabilities

888

1,171

1,504

1,276

807

2,219

4,683

4,974

4,470

3,201

3,186

2,634

3,189

4,292

3,819

4,703

4,042

5,292

7,329

12,923

12,149

8,885

15,292

11,789

9,793

4,841

8,889

8,444

7,478

2,038

2,012

1,478

3,532

2,168

1,699

1,785

1,113

Operating lease liability

123

217

306

362

359

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Litigation settlement payable

-

-

-

-

-

-

0

0

1,300

1,300

1,300

1,300

950

950

0

5,100

5,000

25,000

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current liabilities of discontinued operations

-

-

-

-

-

-

-

-

-

-

6,759

8,685

10,045

6,059

4,195

3,727

4,487

5,925

7,697

-

-

7,169

-

-

-

4,611

-

-

-

-

-

-

-

-

-

-

-

Total current liabilities

3,635

5,290

5,574

5,400

5,804

5,974

11,997

24,852

25,747

24,569

28,021

34,539

36,269

30,398

42,538

47,224

42,222

57,071

37,091

38,114

33,964

27,233

31,586

33,413

26,840

62,473

36,514

25,752

26,379

15,919

10,057

9,322

27,392

11,202

21,461

19,545

5,026

Operating lease liability, non-current

-

-

0

28

112

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred tax liability

262

262

357

357

357

357

1,722

1,722

1,673

1,673

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Convertible notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

500

500

-

0

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

816

877

578

0

Current maturities of capital lease obligations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6

6

6

-

6

6

6

6

6

12

24

35

65

59

51

Fair value of stock options modified (Note 8)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,036

-

Warrant liability

17

52

80

103

991

1,013

975

2,725

1,528

1,309

4,395

8,510

8,325

1,860

9,908

9,264

23,934

14,518

16,661

18,794

14,528

5,383

8,765

15,506

12,365

48,965

24,267

14,909

15,843

10,964

4,904

5,229

20,357

3,746

15,226

14,254

3,138

Capital lease obligations, net of current maturities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

17

19

23

-

30

34

51

51

51

45

36

32

14

10

20

Convertible notes payable, non-current

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,000

-

-

-

-

Deferred tax liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-5,053

-5,053

-5,053

-5,053

-5,053

-5,053

-5,053

-5,053

-5,053

-5,053

-5,053

-5,053

-5,053

-5,053

-5,053

-5,053

-

-

0

Deferred tax liability

-

-

-

-

-

-

-

-

-

-

5,661

5,661

5,661

5,661

5,418

5,418

5,418

5,418

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contingent consideration

5,050

4,912

4,836

4,808

4,713

4,326

5,319

5,157

4,705

1,294

1,277

1,227

1,208

1,095

960

815

6,312

6,142

6,582

6,889

6,972

6,651

6,880

7,477

6,987

6,821

6,454

6,529

6,656

6,207

5,866

5,423

5,297

4,569

4,145

5,664

0

Long-term debt, net of current portion

-

-

-

-

-

-

0

0

1,150

2,611

-

-

-

-

-

-

-

-

1,526

2,546

3,534

4,492

5,097

6,003

6,883

7,743

8,583

9,403

-

0

-

-

-

-

-

-

-

Total liabilities

8,964

10,516

10,847

10,696

11,977

11,670

20,013

34,456

34,803

31,456

34,959

41,427

43,138

37,154

48,916

53,457

53,952

68,631

50,252

52,602

49,523

43,429

48,633

51,965

45,786

82,090

56,634

46,771

38,139

27,230

21,027

19,843

38,778

20,856

25,620

25,219

5,046

Commitments and contingencies (Note 6)

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

0

0

0

0

Stockholders’ equity:
Preferred stock, $0.0001 par value; 5,000,000 shares authorized; Series A convertible preferred stock, 17,500 shares designated; no shares issued and outstanding at March 31, 2020 and December 31, 2019

0

0

0

0

0

0

0

0

0

0

0

0

-

0

-

-

-

0

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

Common stock, $0.0001 par value; 350,000,000 shares authorized, 6,717,900 and 5,080,100 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively.

7

5

5

10

2

1

2

1

1

1

4

4

4

2

20

18

18

15

15

15

15

12

11

11

11

10

10

8

8

8

7

7

5

5

4

4

2

Additional paid-in capital

113,345

107,235

104,360

103,854

89,340

87,099

86,987

65,758

60,861

56,254

347,610

346,026

345,689

335,436

325,175

314,639

312,120

296,730

295,956

294,877

288,936

256,377

242,222

233,501

231,753

188,600

167,111

136,646

132,748

132,168

116,453

115,143

85,263

81,184

77,371

74,321

62,020

Accumulated other comprehensive income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,722

3,513

5,895

1,626

-

-

-

-

-

-

-

Accumulated deficit

-

-

-

-

-

-

-

-

-

-

-

-

-314,650

-

-297,416

-290,487

-295,876

-

-259,705

-241,678

-226,018

-215,481

-207,525

-201,352

-181,411

-178,875

-130,374

-121,087

111,490

-102,197

-98,446

-92,185

-91,989

67,228

-68,817

-63,342

-55,743

Accumulated deficit

-105,300

-101,147

-93,728

-89,526

-86,392

-81,855

-68,532

-68,242

-62,180

-54,185

-329,129

-323,054

-

-302,932

-

-

-

-279,383

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Less treasury shares at cost, 33,750 shares

-

-

-

-

-

-

-

-

-

-

3,849

3,849

3,849

3,849

3,849

3,849

3,849

3,849

3,849

3,849

3,849

3,849

3,849

3,849

3,849

3,849

3,849

3,849

3,849

3,849

3,849

3,849

3,849

3,849

3,849

3,849

3,849

Total stockholders’ equity

8,062

6,093

10,637

14,338

2,950

5,245

18,457

-2,483

-1,318

2,070

14,636

19,127

27,194

28,657

23,930

20,321

12,413

13,513

32,417

49,365

59,084

37,059

30,859

28,311

46,504

5,886

34,620

15,231

23,312

27,756

14,165

19,116

-10,570

10,112

4,709

7,134

2,430

Total liabilities and stockholders’ equity

17,026

16,609

21,484

25,034

14,927

16,915

38,470

31,973

33,485

33,526

49,595

60,554

70,332

65,811

72,846

73,778

66,365

82,144

82,669

101,967

108,607

80,488

79,492

80,276

92,290

87,976

91,254

62,002

61,451

54,986

35,192

38,959

28,208

30,968

30,329

32,353

7,476